—

Defilade Capital Management, L.P.

Q4 2025 13F Holdings

  • Location
    emeryville, CA
  • Num holdings

    33

  • Value ($000)

    $737,727

  • Date Filed
    02/13/2026
  • Form type
    13F-HR
  • CIK
    0002088557
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
P
PFE

PFIZER INC

COM
717081103
$54.87M
7 %

2,203,504

A
ABBV

ABBVIE INC

COM
00287Y109
$52.02M
7 %

227,669

N
NVSN

NOVARTIS AG

SPONSORED ADR
66987V109
$50.02M
7 %

362,816

I
ICUI

ICU MED INC

COM
44930G107
$48.61M
7 %

340,745

P
PACS

PACS GROUP INC

COM SHS
69380Q107
$43.98M
6 %

1,145,485

L
LLY

ELI LILLY & CO

COM
532457108
$34.34M
5 %

31,950

---

STERIS PLC

SHS USD
G8473T100
$34.3M
5 %

135,307

O
OLMA

OLEMA PHARMACEUTICALS INC

COM
68062P106
$30.87M
4 %

1,234,634

R
RVMD

REVOLUTION MEDICINES INC

COM
76155X100
$28.95M
4 %

363,454

B
BIIB

BIOGEN INC

COM
09062X103
$28.51M
4 %

161,992

Rows Per Page
10
  • 5
  • 10
  • 20
  • 30
  • 50
  • 100
1 - 10 of 33